The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Viewpoint: Don’t ignore organic industry’s conflict of interest in stoking fears about glyphosate dangers

A California jury recently awarded a $289 million judgment against Bayer, the maker of the herbicide. Lawyers somehow convinced the jury it caused the plaintiff’s cancer ….

It’s hard not to feel for victims of cancer, but there are several hundred studies concluding glyphosate is safe when it’s properly applied and does not cause cancer ….

Even though all this research was peer reviewed, some people are skeptical because the company funded part of it …. [W]hile financial interests are worth considering in weighing the evidence of safety, those interests alone shouldn’t be cause to dismiss wholesale mountains of independently verified research.

Related article:  Understanding toxicity: Caffeine '40 times more toxic' than glyphosate herbicide

Likewise, the financial interests of activist groups opposed to the use of glyphosate never get the same scrutiny …. Many organic producers and retailers are involved in the anti-glyphosate campaign. Twenty such companies …. signed a petition to get the EPA to place greater restrictions on the use of the herbicide.

Glyphosate kills weeds that choke out production crops …. As a result, foods produced with conventional farming are often cheaper than organic. Organic companies pushing to restrict or ban glyphosate will therefore benefit financially from such laws.

Read full, original article: The debate on glyphosate: Where’s the balance?

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend